Showing results (11-20 of 95) with videos related to

Sort By:
Pageof 10
Clinical Therapeutics|March 4, 2025
Cost-Effectiveness Analysis of SOX Plus Bevacizumab Versus SOX Plus Cetuximab for First-Line Treatment of KRAS Wild-Type Metastatic Colorectal Cancer in JapanTakashi Morimoto, Kaori Fujito, Rei Goto
Asian Pacific Journal of Cancer Prevention : APJCP|April 26, 2014
What is the most effective strategy for improving the cancer screening rate in Japan?Hiroshi Sano, Rei Goto, Chisato Hamashima
Social Science & Medicine (1982)|July 21, 2019
Impact of improved price transparency on patients' demand of healthcare servicesDaiki Kobayashi, Rei Goto, Yusuke Tsugawa
Journal of Health Economics and Outcomes Research|June 29, 2026
Cost-Effectiveness Analysis of Annual vs Biennial Fecal Immunochemical Testing for Colorectal Cancer Screening in Japan: A Microsimulation AnalysisTaichi Mori, Nobuyuki Shimohata, Rei Goto
Journal of Medical Economics|July 3, 2019
Willingness to pay for QALY: perspectives and contexts in JapanAtaru Igarashi, Rei Goto, Mariko Yoneyama-Hirozane
Addiction (Abingdon, England)|May 27, 2009
A cohort study to examine whether time and risk preference is related to smoking cessation successRei Goto, Yuko Takahashi, Shuzo Nishimura, et al.
Clinical and Experimental Nephrology|November 20, 2024
The estimation of healthcare cost of kidney transplantation in Japan using large-scale administrative databasesMasataka Hasegawa, Hirotaka Kato, Takashi Yoshioka, et al.
[Nihon Koshu Eisei Zasshi] Japanese Journal of Public Health|October 3, 2017
Attitudes towards passive smoking at restaurants and effects of the provision of information: A comparison between smokers and non-smokers via a web surveyReiko Yoshikawa, Ataru Igarashi, Rei Goto, et al.
International Journal of Clinical and Experimental Pathology|August 12, 2015
A SMARCB1-deficient vulvar neoplasm with prominent myxoid stroma: report of a case showing ERG and FLI1 expressionShogo Tajima, Yusuke Takahasi, Michi Hikoaki, et al.
Clinical Therapeutics|January 14, 2023
Cost-effectiveness Analysis of Monoclonal Antibodies in the First-line Treatment of RAS Wild-type Metastatic Colorectal Cancer: A Systematic ReviewTakashi Morimoto, Kaori Fujito, Bumpei Yamasaki, et al.
Pageof 10